Latest Regulatory Approvals News

NSX Limited has entered a Scheme Implementation Deed with CNSX Markets Inc. for a full acquisition at a 59% premium, subject to shareholder and regulatory approvals. The deal aims to strengthen NSX’s market position and expand its product offerings.

Arizona Lithium has achieved a landmark regulatory approval for Phase 1 production at its Prairie Lithium Project, marking the first lithium brine operation sanctioned in Saskatchewan. Updated drilling and modeling have significantly expanded the project's resource base and production potential.

Yari Minerals has completed the acquisition of the Rolleston South Coal Project in Queensland’s Bowen Basin, adding a substantial 78.9 million tonnes inferred coal resource and planning further drilling to expand it.

Askari Metals offers holders of expired AS2O options a priority issue of new options, while advancing due diligence on a promising Ethiopian gold project.

Korea National Oil Corporation is set to acquire a 29% stake in the Otway Basin joint venture with 3D Energi and ConocoPhillips, strengthening the exploration push for East Coast Australia’s gas supply.

Empire Energy Group has launched a $28 million equity raise to fund critical development activities at its Beetaloo Basin shale gas project, aiming for first gas sales in 2025. The capital will support fracture stimulation, flow testing, and installation of the Carpentaria Gas Plant.

Empire Energy has successfully raised $28 million through a placement and launched a $3 million Share Purchase Plan to fund critical development of its Carpentaria-5H well in the Beetaloo Sub-basin.

ECS Botanics is on track for a record-breaking FY25 harvest with a 50% production increase and new premium product launches, signaling strong growth and a positive cash flow outlook.

Midas Minerals has announced a transformative acquisition of the Otavi Copper-Gold-Silver Project in Namibia, unlocking significant exploration potential with plans to commence drilling later this year.

Metgasco Ltd has announced a non-renounceable entitlement offer to raise approximately $0.75 million at a discounted price of 0.2 cents per share, aiming to fund production uplift programs and working capital. The offer is partially underwritten and includes a Top-Up Facility for eligible shareholders.

Manuka Resources’ Taranaki VTM Project has cleared a key regulatory hurdle, moving forward in New Zealand’s Fast-track Approvals Process with promising economic and environmental prospects.

Mayne Pharma Group has proposed a $7.40 per share acquisition by Cosette Pharmaceuticals, with unanimous board support and a fair and reasonable opinion from an independent expert. Shareholders will vote on the scheme on June 18, 2025.